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2 Objectives. In patients at low clinical probability of acute aortic syndromes (AASs), decision on advanced 
3 aortic imaging is cumbersome. Integration of the aortic dissection detection risk score (ADD-RS) with D-
4 dimer (DD) provides a potential pipeline for standardized diagnostic rule-out. We systematically reviewed and 
5 summarized supporting data.
6
7 Methods. Cross-sectional studies assessing integration of ADD-RS with DD for diagnosis of AASs were 
8 identified on MEDLINE, EMBASE and Web Of Science databases. Two reviewers independently screened 
9 articles, assessed quality and extracted data. The quality of design and reporting was evaluated with the 
10 QUADAS-2 and STARD tools. Individual patient data were obtained, to allow analysis of both conventional 
11 (500 ng/mL) and age-adjusted (DDage-adj) DD cutoffs. Data were summarized for 4 diagnostic strategies 
12 combining ADD-RS=0 or ≤1, with DD<500 ng/mL or <DDage-adj. The statistical heterogeneity of the diagnostic 
13 variables was estimated with Higgins’ I2. Pooled values were calculated for variables showing non-significant 
14 heterogeneity.
15
16 Results. After screening of 680 studies, 4 articles (including a total of 3804 patients) met inclusion criteria. 
17 One prospective study provided a low risk of bias/applicability concerns, while methodological limitations 
18 were found in the other 3 retrospective studies. Statistical heterogeneity was negligible for sensitivity and 
19 negative likelihood ratio (LR) values, and significant for specificity and positive LR values of all diagnostic 
20 strategies. Pooled sensitivity was 99.9% (95%CI 99.3–100%, I2=0) for ADD-RS=0 and DD<500 ng/mL or 
21 <DDage-adj, 98.9% (95%CI 97.9–99.9%, I2=0) for ADD-RS≤1 and DD<500 ng/mL and 97.6% (95%CI 96.3–
22 98.9%, I2=0) for ADD-RS≤1 and DD<DDage-adj. 
23
24 Conclusions. Despite methodological limitations, integration of ADD-RS=0 or ≤1 with DD<500 ng/mL shows 
25 negligible heterogeneity and consistently high sensitivity across studies, thus supporting reliability for 
26 diagnostic rule-out of AASs. Data supporting ADD-RS=0 plus DDage-adj appear preliminary and require further 
27 scrutiny.




2 Acute aortic syndromes (AASs) are deadly cardiovascular emergencies involving the thoracic aorta. 
3 They include acute aortic dissection, intramural aortic hematoma, penetrating aortic ulcer and aortic rupture.1 
4 AASs represent unique diagnostic challenges because they are relatively rare diseases (4-6 cases/100.000 
5 individuals/year), but their presenting symptoms are unspecific and frequent in Emergency Department (ED) 
6 visits. For instance, chest pain accounts for 6% of ED visits (8-10 million visits/year in the US), abdominal 
7 pain for 6% and syncope for 2%.2-5 Conclusive diagnosis requires advanced imaging techniques, mostly 
8 contrast-enhanced computed tomography angiography (CTA), but owing to radiation, contrast exposure and 
9 resource limitations, CTA cannot be performed in all patients with AAS-compatible symptoms.6 
10 Consequently, decision on advanced imaging for suspected AASs is cumbersome, as shown by substantial 
11 variability in CTA ordering within emergency physicians, high misdiagnosis rates (up to 39%) and low 
12 diagnostic efficiency (as low as 2% of CTA exams turning out positive in North American series).7-9
13 For standardized clinical probability assessment of AASs, the reference tool indicated by guidelines is 
14 the aortic dissection detection risk score (ADD-RS), based on 12 risk factors organized in 3 categories 
15 (supplementary table 1).10,11 Using the ADD-RS, patients can be classified in 3 risk-categories (ADD-RS=0 or 
16 low risk, ADD-RS=1 or intermediate risk, ADD-RS>1 or high risk), or in 2 risk-categories (ADD-RS≤1 or 
17 low probability, ADD-RS>1 or high-probability). In guidelines by the European Society of Cardiology (ESC) 
18 and American College of Cardiology (ACC)/American Heart Association (AHA), standardized probability 
19 assessment, in association with thorough physical examination, history collection and clinical reasoning, 
20 designs a pipeline for standardized diagnostic evaluation of stable patients with suspected AASs. However, 
21 the ADD-RS does not substitute clinical reasoning and is not recommended by the American College of 
22 Emergency Physicians (ACEP) in isolation.12
23 D-dimer (DD), a fibrinogen degradation product well-established for the rule-out of pulmonary 
24 embolism (PE), is also a highly sensitive and moderately specific biomarker of AASs.13,14 The standard DD 
25 cutoff for AASs is 500 ng/mL. A key determinant of DD specificity is age, with a higher incidence of false 
26 positive results in elderly patients. For PE rule-out, application of an age-adjusted DD (DDage-adj) increases 
27 specificity and efficiency without affecting sensitivity.15 Two studies have reported that also for AASs, DDage-
28 adj may increase specificity with a small trade-off in sensitivity.16,17 A single cutoff for PE and AASs could be 
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1 very practical, as both conditions are invariably considered in differential diagnosis in patients with truncal 
2 pain and both imply decision on CTA.18
3 The rationale of integrating ADD-RS with DD testing is that very few cases of AASs are predicted to 
4 occur in patients with ADD-RS=0 or ≤1 and a negative DD test result.14,19  In the present study, we aimed to 
5 provide a systematic review of studies evaluating the integration of ADD-RS with DD. For diagnostic variables 
6 with low statistical heterogeneity across studies, we aimed to determine pooled estimates. In order to also 






13 The study protocol was registered in the international prospective register of systematic reviews 
14 (PROSPERO) website, with CRD42019137508. This study followed PRISMA statement and the 
15 recommendations included in the Cochrane Handbook Accuracy and in the PRISMA-DTA statement.20,21 
16 Institutional review board ethical approval was not needed because of the reviewing nature of this study.
17
18 Search strategy
19 In June 2019, we conducted a thorough online search on MEDLINE, EMBASE and Web Of Science 
20 databases. Detailed search strategies are presented in table 1. We subsequently hand-searched the reference 
21 lists of all articles identified in our searches and of systematic reviews and meta-analyses on this topic.
22
23 Inclusion/exclusion criteria
24 Two investigators independently reviewed the titles and abstracts of the studies to assess eligibility. 
25 The full text article of the potentially eligible articles was next obtained to evaluate inclusion/exclusion criteria. 
26 Any disagreement was solved by consensus. The study design was gathered from Asha et al., representing the 
27 reference meta-analysis for DD in AASs.14 Studies were included if: (1) they were original research primarily 
28 assessing integration of ADD-RS with DD for the diagnosis of AASs; (2) they were cross-sectional diagnostic 
Page 3 of 60 Academic Emergency Medicine
For Review Only
4
1 studies; (3) prospective or retrospective enrollment was based on one or more AAS-compatible symptoms 
2 amongst chest pain, abdominal pain, back pain, syncope, perfusion deficit; (4) the ADD-RS was calculated; 
3 (5) the DD level was measured; (6) the diagnosis was confirmed or excluded with satisfactory criteria 
4 (advanced imaging with CTA, transesophageal echocardiography, magnetic resonance angiography, 
5 aortography, surgery or autopsy; in alternative, clinical case adjudication based on clinical data review and/or 
6 follow-up data); (7) absolute numbers of true positive, true negative, false positive, and false negative were 
7 reported or could be derived. 
8 Studies were excluded if the design was case-control or case series due to high potential biases and the 
9 impossibility to calculate pre-test probability.22 Conference abstracts were excluded because they are not peer-
10 reviewed, the results may not be final and insufficient detail is provided for quality assessment.
11
12 Data extraction and analysis
13 The reporting of this systematic review follows the Preferred Reporting Items for a Systematic Review 
14 and Meta-analysis of Diagnostic Test Accuracy Studies (PRISMA-DTA checklist, provided as supplementary 
15 tables 2).21 Two reviewers extracted data independently from the selected articles. The extracted data included: 
16 first author, date of publication, study period, number of study sites, study setting, study design, 
17 inclusion/exclusion criteria, number of participants analyzed and excluded, D-dimer assay used, D-dimer 
18 reference range, reference standard used. They also extracted the study population characteristics (age, gender, 
19 time from symptom onset to evaluation), ADD-RS distribution, D-dimer level, AAS subtype, alternative final 
20 diagnoses made for patients without AASs, reporting the absolute number of true positive (TP), true negative 
21 (TN), false positive (FP), false negative (FN). 
22 Two investigators independently assessed the quality of study design using the QUADAS-2 tool and 
23 the quality of reporting using the STARD tool.23,24 QUADAS-2 assessment was done in compliance with the 
24 original background document.23 For the domain “patient selection”, we identified a high risk of bias if the 
25 sample was not consecutive, if the study wasn’t done in the ED, if symptoms leading to patient inclusion did 
26 not include at least chest pain (representing the most common presenting symptom of AASs) and if patient 
27 enrollment was based on results of D-dimer or advanced imaging and not on clinical presentation. For the 
28 domain “index test”, we identified a high risk of bias if the threshold of the index test wasn’t prespecified or 
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1 if the result of the index test was interpreted after applying the reference standard. For the domain “reference 
2 standard”, a high risk of bias was identified if patients were not subjected to advanced aortic imaging (CTA, 
3 transesophageal echocardiography, magnetic resonance angiography or aortography), surgery or autopsy. For 
4 patients not subjected to advanced imaging, surgery or autopsy, case adjudication based on independent 
5 clinical data review and/or follow-up data was considered satisfactory.  For the domain “flow and timing”, a 
6 high risk of bias was identified if studies included a significant (>5%) proportion of patients evaluated >14 
7 days after symptom onset. Agreement between the reviewers was assessed with Cohen’s k statistic. Types of 
8 diagnostic bias and anticipated skews in observed sensitivity/specificity were evaluated according to Kohn et 
9 al.22
10 Based on clinical reasoning and previous evidence, we planned to analyze the DD test results based 
11 on two different cutoffs: 500 ng/mL and an age-adjusted cutoff (DDadj).18 For the latter, the DD result was 
12 interpreted as follows: in patients younger than 50 years, an AAS was excluded in those with a DD value lower 
13 than 500 ng/mL. In patients aged 50 years or older, the DD test result was considered negative in those with a 
14 DD value lower than their age multiplied by 10. Briefly, DDadj (ng/mL) was calculated as: age (years) × 10 
15 ng/mL (with a minimum of 500 ng/mL).15 To conduct an individual patient-level meta-analysis, the authors of 
16 all the selected studies were contacted to obtain missing data. For each study, a database was obtained reporting 
17 for each included patient, the age in years, the ADD-RS, the absolute DD level and the final diagnosis. 
18 In the meta-analysis, we analyzed the performance of the following integrated strategies for diagnostic 
19 rule-out of AASs (i.e. if string satisfied, rule-out AASs): (1) ADD-RS≤1 and DD<500 ng/mL; (2) ADD-RS≤1 
20 and DD<DDage-adj; (3) ADD-RS=0 and DD<500 ng/mL; (4) ADD-RS=0 and DD<DDage-adj. We built 2 x 2 
21 contingency tables for each diagnostic strategy using the number of true positive (TP), false positive (FP), false 
22 negative (FN), true negative (TN). For negative likelihood ratio (LR) values of strategies with a sensitivity of 
23 100%, contingency tables with zero value were handled by adding a 0.5 continuity correction and the 95% CI 
24 was estimated using a bootstrapping approach.25 The failure rate was calculated as FN / (FN+TN), i.e. number 
25 of patients with AASs satisfying rule-out criteria divided by the total number of patients satisfying rule-out 
26 criteria.26 The rule-out efficiency was calculated as (TN+FN) / (TP+FP+TN+FN), i.e. number of patients ruled-
27 out by each integrated strategy divided by total number of patients tested. Heterogeneity was determined using 
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1 the Higgins’ I2. For variables showing non-significant heterogeneity, we calculated pooled values using fixed 
2 or random models as appropriate, based on inter- and intra-study variability. 
3 The Pauker and Kassirer decision threshold model was applied to calculate two theoretical thresholds: 
4 a testing threshold (i.e. the probability of AAS at which there is no difference between performing the test and 
5 withholding the treatment) and a test-treatment threshold (i.e. the probability of AAS at which there is no 
6 difference between performing the test and administering the treatment).27 





12 Within 680 studies identified by the systematic database research, 12 studies were selected for full-
13 text review (figure 1) and 4 studies met all the inclusion criteria.16,28-30 Three studies were designed to 
14 investigate the diagnostic test characteristics of ADD-RS plus DD<500 ng/mL,28-30 and one investigated the 
15 integration of ADD-RS with DD<DDage-adj.16 The study characteristics are summarized in table 2 and the final 
16 diagnoses of the participant patients are detailed in supplementary table 3. The case-mix of AASs was similar 
17 amongst studies, with acute aortic dissection representing the most frequent subtype and intramural aortic 
18 hematoma or penetrating aortic ulcer accounting for most of the other cases. Some specificities were found in 
19 the study by Kotani et al., which included a larger number of patients with complicated aneurysms 
20 (ruptured/with impending-rupture or infectious).16 This study also reflects the higher prevalence of intramural 
21 hematomas in Japan and Asia. The pooled prevalence of AASs (mean ± SD) across the four studies was 18.0% 
22 ± 5.3%, which is substantially higher than reported in North American ED series, but also substantially lower 
23 than in most diagnostic biomarker studies, including the first key prospective multicenter study of D-dimer.9,31-
24 33 The pooled prevalence of “classic” acute aortic dissection was 67.3%, of intramural aortic hematoma was 
25 18.7% and of penetrating aortic ulcer was 6.8%. A higher observed prevalence of AASs than in general ED 
26 practice could lead to spectrum bias (falsely raising sensitivity).
27 The study by Nazerian et al. (2018) was the only prospective multicenter study. Its primary aim was 
28 to define the failure rate of a diagnostic rule-out strategy integrating ADD-RS (=0 or ≤1) with DD<500 
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1 ng/mL.30 A secondary analysis applying DDage-adj has also been published.17 In this trial, the gold standards for 
2 case-adjudication were conclusive aortic imaging (by CTA, transesophageal echocardiography or magnetic 
3 resonance angiography), surgery or autopsy. Enrollment preceded final decision on aortic imaging, and 
4 patients who were not subjected to any of these gold standards during the ED visit were subjected to 14-day 
5 follow-up. Patients or family members were interviewed by telephone with a structured questionnaire or 
6 underwent an outpatient visit after ED discharge, evaluating diagnosis of any aortic disease, subsequent ED 
7 visits, hospital admission and death. Reviewers defining case adjudication had access to hospital charts and 
8 discharge documents. Gold standard imaging was obtained during the index visit in 45% of patients, and during 
9 follow-up in 1.6% of patients. Patients dismissed from the ED and with a negative follow-up were 34.3%, 
10 potentially leading to differential verification bias, with a decrease in observed sensitivity and specificity. 
11 During follow-up, 2 patients were lost and 3 cases of AASs were diagnosed. Three patients died without 
12 advanced imaging or surgery. They all had a positive DD test result and therefore could not be regarded as 
13 potential FN cases.
14 The studies by Nazerian et al. (2014), Gorla et al. and Kotani et al. were retrospective.16,28,29 In these 
15 studies, an exact time definition of symptoms triggering enrollment was not reported by the authors. This raises 
16 concern about the potential inclusion of patients with non-acute symptoms, in whom the chance of FN cases 
17 is higher. In the study by Nazerian et al. (2014), data were obtained from a registry of ED patients undergoing 
18 advanced aortic imaging for clinically suspected AAS.28 The study cohort largely overlapped with another 
19 study from the same groups which focused on validation of the ADD-RS per se.34 For 29% of enrolled 
20 participants, a DD test result was not available, leading to patient exclusion. This could introduce partial 
21 verification bias (which could raise sensitivity), but the characteristics of the patients in the included and 
22 excluded groups were similar. A post-hoc analysis showed that only 17 patients (1.6%) presented with history 
23 of pain >14 days; 4 of them had an AAS. One of these patients (symptoms for 15 days), had a normal D-dimer. 
24 However, exact time data was missing for 39.2% of the enrolled patients.  
25 In Gorla et al.,29 patients were enrolled if they were admitted to the ED for chest pain and if they were 
26 subjected to a DD assay. These criteria could bias against atypical presentations not involving chest pain. The 
27 clinical judgment of the physician ordering DD was not recorded. Hence, PE and not AAS could have 
28 represented the chief differential diagnosis in some patients. Indeed, the rate of PE in this cohort was 14.5%, 
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1 significantly higher than in the other studies. The authors declare that in study patients, CTA was used per 
2 guidelines, based on clinical judgment and on DD test result. All diagnoses of AASs were confirmed by 
3 advanced aortic imaging. Since the actual number of patients subjected to advanced imaging is unknown and 
4 clinical case adjudication was not based on a pre-specified follow-up, observed sensitivity could be raised due 
5 to differential verification bias.
6 In the study by Kotani et al.,16 patients were also enrolled if they presented with acute chest pain and 
7 if they received a DD assay. The exact time interval from symptom onset to sampling was not presented, and 
8 the DD assay was used per a pre-specified hospital protocol not detailed in the manuscript. The analysis was 
9 conducted only on patients admitted to hospital after the ED visit, while patients dismissed from the ED were 
10 excluded. This could lead to spectrum bias, raising sensitivity in the enrolled sample. Restriction to admitted 
11 patients potentially biases towards a more clinically severe population, while rule-out strategies ideally apply 
12 to patients in whom early ED discharge represents a meaningful option. However, the final prevalence of AASs 
13 was 13.9%, indicating adequate representation of low-probability patients. Additional exclusion criteria were 
14 ST elevation on ECG and hemodynamic instability. Both criteria are in line with ESC recommendations, as 
15 patients with these clinical characteristics are not amenable to rule-out criteria.11 The DD assay was interpreted 
16 using the DDage-adj cutoff. As in Gorla et al., enrollment criteria focused on chest pain, excluding alternative 
17 clinical presentations and likely included patients with a clinical suspicion of PE and not only of AASs. 
18 However, the prevalence of PE was generally low (3.8%), while the prevalence of acute coronary syndromes 
19 was the highest, indicating potential bias towards coronary artery disease.
20
21 Quality assessment
22 The quality assessment (QA) conducted using the QUADAS-2 is shown in table 3 and in 
23 supplementary figure 1. For only one study, the judgment was “low” in all 7 domains, indicating an overall 
24 low risk of bias and concern regarding applicability.30 In one study, the judgment was “low” in 3 of 7 
25 domains.29 
26 The quality of reporting of the included studies, analyzed according to the STARD 2015 statement, is 
27 detailed in supplementary table 4. Most studies showed suboptimal quality regarding type of sample 
28 enrollment, how missing data on the index test and reference standard were handled, sample size calculation, 
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1 whether any clinical intervention was done between the index test and the reference standard, study registration 
2 and accessibility of the full protocol. The agreement between the reviewers for components of the study quality 
3 assessment tools was good (κ=0.67, 95% CI 0.54 – 0.80).35
4
5 Meta-analysis
6 A total of 3804 patients were included in the meta-analysis, including 675 (17.7%) with AASs. To 
7 evaluate strategies integrating either the 500 ng/mL or the DDage-adj cutoff, individual patient-level data were 
8 used. Contingency tables and coupled forest plots were obtained (figure 2). For all strategies, statistical 
9 heterogeneity was negligible for sensitivity (I2=0%) and significant for specificity values. Subanalyses 
10 excluding patients with ADD-RS=0, shown in supplementary tables 5-6, indicated that results were not 
11 substantially affected by inclusion of patients at lowest pre-test probability of AASs. Negative and positive 
12 likelihood ratio (LR) values of the diagnostic strategies are shown in figure 3. Heterogeneity was negligible 
13 for the negative LR (I2=0%) and significant for the positive LR values of the diagnostic strategies.
14 Forest plots of failure rate and efficiency values are shown in figures 4-5. Failure rate values had low 
15 to moderate heterogeneity for ADD-RS=0 and DD<500 ng/mL (I2=38.1%), ADD-RS=0 and DD<DDage-adj 
16 (I2=28%), ADD-RS≤1 and DD<500 ng/mL (I2=39%); heterogeneity was significant for ADD-RS≤1 plus 
17 DD<DDage-adj (I2=84.4%). Efficiency values had significant heterogeneity for all diagnostic strategies. 
18 Pooled estimates of diagnostic variables underlying diagnostic rule-out (sensitivity, negative LR and 
19 failure rate) and showing non-significant heterogeneity across studies are summarized in table 4. Diagnostic 
20 variables showing high heterogeneity were not to reported, as limited inference on pooled values can be done. 
21 For ADD-RS=0 and DD<500 ng/mL, pooled sensitivity was 99.9% (99.3–100%), negative LR 0.032 (0–0.086) 
22 and failure rate 0.1% (0–0.3%). For ADD=0 and DD<DDage-adj sensitivity was 99.9% (99.3–100%), negative 
23 LR 0.027 (0–0.081) and failure rate 0.1% (0–0.2%). For ADD-RS≤1 and DD<500 ng/mL, sensitivity was 
24 98.9% (97.9–99.9%), negative LR 0.025 (0.001–0.049) and failure rate 0.6% (0.2–0.9%). For ADD-RS≤1 and 
25 DD<DDage-adj, sensitivity was 97.6% (96.3–98.9%) and negative LR 0.048 (0.022–0.074). For this strategy, 
26 pooled failure was not computed due to significant heterogeneity.
27
28 Test-treatment threshold
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1 Test-treatment thresholds were calculated for diagnostic strategies including DD<500 ng/ml 
2 (supplementary figure 2). According to this model, the ADD-RS=0 and DD<500 ng/mL strategy should be 
3 performed if the clinical probability of AASs is between 1.7% and 23.2%, while the ADD-RS≤1 and DD<500 




8 We provide a systematic review and summary of studies assessing integration of ADD-RS with DD 
9 for diagnosis of AASs. Only four papers satisfied the pre-defined inclusion criteria, underlying the relative 
10 paucity of data. However, the total number of included patients was substantial (n=3804). All studies post-
11 dated the latest guidelines of the American Heart Association and the European Society of Cardiology, and 
12 only one (Nazerian et al. 2014) was cited in the latest clinical policy of the American College of Emergency 
13 Physicians.11,12,36 One was a prospective multicenter trial, while the other 3 were retrospective studies. All were 
14 performed in the ED and mostly involved patients with chest pain, but inclusion criteria partly differed. This 
15 key limit reflects the absence of a standard definition of patients suspected of having AASs and amenable to 
16 rule-out strategies. Therefore, methodological and clinical heterogeneity between available studies mandate 
17 caution in efforts to pool and summarize data.
18 Significant statistical heterogeneity was found for specificity, positive LR and efficiency. This likely 
19 reflects differences in the clinical case-mix of study cohorts. For these variables, data pooling could be 
20 misleading and was therefore omitted. AASs cases were instead homogenous across studies, thus leading to 
21 negligible statistical heterogeneity for sensitivity and negative LR values and allowing meaningful data 
22 pooling for these variables. Also in a previous meta-analysis of high-quality studies (which also included 
23 Nazerian et al. 2014), the heterogeneity was low for sensitivity and negative LR, and substantial for specificity 
24 and positive LR.14  
25 Acquisition of primary data allowed us to evaluate diagnostic strategies incorporating also DDage-adj, 
26 already in use for PE rule-out. When using ADD-RS=0, DDage-adj provided pooled sensitivity and negative LR 
27 values similar to those of the “classical” 500 ng/mL cutoff. Instead, when using ADD-RS≤1, DD<500 ng/mL 
28 outperformed DD<DDage-adj in terms of pooled sensitivity and negative LR. This data suggests that DD<DDage-
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1 adj could be evaluated in further studies only if the pre-test probability is presumed to be very low. DDage-adj 
2 might provide increased specificity over 500 ng/mL, but the statistical heterogeneity found across studies does 
3 not allow any conclusion. 
4 Consensus is lacking on what should reproducibly define a clinical suspicion of AASs. Hence, 
5 differences between physicians and centers can be profound. In North American retrospective series of patients 
6 undergoing CTA for suspected AAS, the prevalence of AASs was 3%.8,37 In a vast out-of-hospital study 
7 evaluating the ADD-RS in non-traumatic emergencies, the prevalence of AASs was 0.9%.38 In the studies 
8 reviewed herein, the prevalence of AASs was 13 to 23%. Application of rule-out strategies to patient 
9 populations at lower pre-test probability of AASs is expected to result in lower failure rates, with a trade-off 
10 in efficiency.
11 Caution is needed when considering application of ADD-RS and D-dimer based strategies in clinical 
12 practice. First, ADD-RS, a decision rule derived from a retrospective register of AASs, has low specificity.37 
13 In addition, ADD-RS derivation methods have not been published, and it is currently unknown whether use of 
14 the ADD-RS provides any advantage in terms of diagnostic accuracy and of CTA ordering, as compared to 
15 clinical gestalt.39,40 In the future, focused ED-centered studies may provide alternative and more specific 
16 probability assessment tools. Second, D-dimer also lacks specificity. Therefore, indiscriminate application of 
17 ADD-RS and D-dimer to unselected ED patients with AAS-compatible symptom(s) would paradoxically 
18 increase the number of CTA ordered. Such slippery slope must be avoided.41 
19 Based on previous data, in terms of specificity, we speculate that the ADD-RS/D-dimer rule-out 
20 pathway could best apply to stable patients with ADD-RS=1 owing to clinical manifestations providing per se 
21 higher specificity (i.e. pulse deficit, neurological deficit, aortic valve insufficiency).42 Caution is needed in 
22 patients with hypotension, which also potentially defines clinical instability and might prompt towards a fast-
23 track for advanced imaging irrespective of D-dimer test results. However, in clinical practice, most cases with 
24 ADD-RS=1 will be driven by pain features (severe, sudden, ripping pain), providing higher sensitivity but 
25 lower specificity. To maximize benefits, a pragmatic approach could be to request D-dimer only after three-
26 dimensional evaluation of clinical history, physical examination, first-line imaging and blood test results, in 
27 patients still lacking a clear alternative diagnosis, or in whom  rule-out of AASs is considered imperative for 
28 decision on hospital admission versus discharge or administration of anticoagulant/antiplatelet therapies, 
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5 Only one study (49% of patients) was judged to provide a low risk of bias/applicability concerns.30 
6 Two studies (42% of patients)16,28 had issues in one of the QUADAS domains, and one study (10% of patients) 
7 had a generally lower quality profile.29 In one study, the case-mix of AASs slightly differed, with fewer cases 
8 of acute aortic dissections and higher prevalence of the other forms.16 Overall, the potential bias types most 
9 frequently encountered were: (1) partial verification bias, due to patients excluded because discharged from 
10 the ED or due to unavailable DD test result (leading to potential upward skew in sensitivity and downward 
11 skew in specificity), and (2) differential verification bias, due to inclusion of patients subjected to clinical 
12 follow-up without advanced aortic imaging (leading to potential downward skew in sensitivity and specificity). 
13 The accuracy of DD for diagnosis of AASs may also slightly differ amongst subtypes, with higher risk of false 
14 negative cases in patients with intramural hematomas and focal dissections.43,44 Therefore, methodological and 
15 clinical heterogeneity between available studies mandate caution in data pooling and summarization.
16 A key issue affecting two studies (24% of patients) is that the authors selected patients with chest pain 
17 and a DD test result, potentially also introducing individuals with suspected PE.16,29 In clinical terms, this 
18 aspect may be secondary, because both PE and AASs are typically considered in differential diagnosis, share 
19 DD as the key biomarker and require CTA for conclusive diagnosis. A suspicion of AAS by the attending 
20 physicians was clearly defined in two studies (76% of patients) led by the same primary investigators.28,30 This 
21 might limit external validity.
22 With the exception of the ADvISED trial, there was general uncertainty about the timing of the index 
23 test. Hence, a minority of patients with symptoms dating >14 days were possibly enrolled, including few cases 
24 of AASs in their subacute or chronic phase. Since D-dimer levels tend to decrease over time after development 
25 of AASs, this is expected to increase the number of patients with AASs presenting as FN (differential 
26 verification bias, with potential downward skew in estimates of sensitivity and failure rate).45
27
28




2 Only 4 studies have evaluated integration of ADD-RS with DD for diagnosis of AASs, with 
3 methodological differences that must be carefully considered. However, the total number of included patients 
4 is reasonably large (n=3804), and negligible heterogeneity was found for sensitivity and negative LR values. 
5 Available studies consistently show that ADD-RS=0 or ≤1 plus DD<500 ng/mL are highly sensitive diagnostic 
6 strategies and support their reliability for rule-out of AASs. For DDage-adj, available data appear largely 
7 preliminary and further studies are required. Nonetheless, further prospective trials, especially in low 
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13 Figure 1. PRISMA flow diagram of study search and selection.
14
15 Figure 2. Contingency tables and coupled forest plots of sensitivity and specificity values. Heterogeneity was 
16 determined using the Higgins’ I2.
17
18 Figure 3. Forest plots of the negative and positive likelihood ratio values. Heterogeneity was determined 
19 using the Higgins’ I2.
20
21 Figure 4. Forest plots of the failure rate values. Heterogeneity was determined using the Higgins’ I2.
22
23 Figure 5. Forest plots of the efficiency values. Heterogeneity was determined using the Higgins’ I2.




Table 1. Detailed database search strategies.
Literature database Search query
MEDLINE (((("Aneurysm, Dissecting"[Mesh]) AND "Fibrin Fibrinogen Degradation 
Products"[Mesh]) OR (acute aortic syndrome AND D-dimer))) OR "Aortic 
Dissection Detection Risk Score")
EMBASE (('acute aortic syndrome'/exp OR 'acute aortic syndrome' OR 'aortic 
dissection'/exp OR 'aortic dissection') AND ('d dimer'/exp OR 'd dimer') OR 
'aortic dissection detection risk score') NOT 'conference abstract':it NOT 
review:it NOT letter:it
Web Of Science TOPIC: (("acute aortic syndrome" OR "aortic dissection" OR "dissecting 
aneurysm" OR "Aortic Dissection Detection Risk Score") AND ("D-dimer" OR 
"Fibrin Degradation Product"))
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Table 2. Characteristics of included studies.
Nazerian, 2014 Gorla, 2017 Kotani, 2017 Nazerian, 2018
Study period 01/2008 to 03/2013 01/2001 to 05/2014 01/2011 to 04/2014 01/2014 to 12/2016
























420 (29%) 0 (0%) 66 (6.9%) 48 (2.5%)
AASs, N (% enroll.)
   AD, N (% AAS)
   IMH, N (% AAS)
   PAU, N (% AAS)






















(N, % with AAS)
   0
   1























perfusion deficit + 
alt-D not
 established + 
clinical suspicion 
leading to CTA
chest pain + D-
dimer available at 
presentation
acute chest pain + 
admission to 
hospital + D-dimer 
available
chest/back/abdomin
al pain, syncope or 
perfusion deficit + 
clinical suspicion
Exclusion criteria NR NR
hemodynamic 
instability, STEMI, 
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in ED, referral to 
other hospital






CTA, TEE, MRA, 




Age, y mean (SD) 67 (14%) 63 (12%) 70 (14%) 62 (12%)
Male, % 66% 61% 63.4% 62.3%
Duration of 
symptoms, hours
















<500 ng/ml ≤500 ng/ml
if age ≤50y: < 500 
ng/ml




   sensitivity 









AAS: acute aortic syndrome; AD: aortic dissection; alt-D: alternative diagnosis; BR: Brazil; CTA: computed 
tomography angiography; GE: Germany; IMH: intramural aortic hematoma; IQR: interquartile range; IT: Italy; 
JA: Japan; MRA: magnetic resonance angiography; NR: not reported; PAU: penetrating aortic ulcer; SD: 
standard deviation; SW: Switzerland; TEE: transesophageal echocardiography. 
*Values reported as median (IQR). §Original data provided by the authors for the present analysis and not 
included in the original manuscript. #Includes: ruptured aortic aneurysm (7.3%), impending rupture of aortic 
aneurysm (10.6%), infectious aortic aneurysm (3.2%). ¶Includes only spontaneous (non-traumatic) rupture of 
thoracic aorta.
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Table 3. Assessment of study quality according to QUADAS-2.23














Nazerian, 2014 L L L U L L L
Gorla, 2017 H L U U L L U
Kotani, 2017 H L L L L L L
Nazerian, 2018 L L L L L L L
L =Low-risk, H =High-risk, U =Unclear
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1 in 1000 
(333–∞)
     I-squared, p 0%, 0.95 0%, 0.64 38.1%, 0.18






1 in 1000 
(500–∞)
     I-squared, p 0%, 0.95 0%, 0.77 28%, 0.24








     I-squared, p 0%, 0.91 0%, 0.98 39%, 0.19





     I-squared, p 0%, 0.86 0%, 0.56 84.4%, <0.001
LR: likelihood ratio; n.a.=not applicable due to significant heterogeneity.




2 Objectives. In patients at low clinical probability of acute aortic syndromes (AASs), decision on advanced 
3 aortic imaging is cumbersome. Integration of the aortic dissection detection risk score (ADD-RS) with D-
4 dimer (DD) designs aprovides a potential pipeline for standardized diagnostic rule-out. We systematically 
5 reviewed and summarized supporting data.
6
7 Methods. Cross-sectional studies assessing integration of ADD-RS with DD for diagnosis of AASs were 
8 identified on MEDLINE, EMBASE and Web Of Science databases. Two reviewers independently screened 
9 articles, assessed quality and extracted data. The quality of design and reporting was evaluated with the 
10 QUADAS-2 and STARD tools. Individual patient data were obtained, to allow analysis of both conventional 
11 (500 ng/mL) and age-adjusted (DDage-adj) DD cutoffs. Data were summarized for 4 diagnostic strategies 
12 combining ADD-RS=0 or ≤1, with DD<500 ng/mL or <DDage-adj. The statistical heterogeneity of the diagnostic 
13 variables was estimated with Higgins’ I2. Pooled values were calculated for variables showing non-significant 
14 heterogeneity.
15
16 Results. After screening of 680 studies, 4 articles (including a total of 3804 patients) met inclusion criteria. 
17 One prospective study provided a low risk of bias/applicability concerns, while methodological limitations 
18 were found in the other 3 retrospective studies. Statistical heterogeneity was negligible for sensitivity and 
19 negative likelihood ratio (LR) values, and significant for specificity and positive LR values of all diagnostic 
20 strategies. Pooled sensitivity was 99.9% (95%CI 99.3–100%, I2=0) for ADD-RS=0 and DD<500 ng/mL or 
21 <DDage-adj, 98.9% (95%CI 97.9–99.9%, I2=0) for ADD-RS≤1 and DD<500 ng/mL and 97.6% (95%CI 96.3–
22 98.9%, I2=0) for ADD-RS≤1 and DD<DDage-adj. 
23
24 Conclusions. Despite methodological limitations, integration of ADD-RS=0 or ≤1 with DD<500 ng/mL shows 
25 negligible heterogeneity and consistently high sensitivity across studies, thus supporting reliability for 
26 diagnostic rule-out of AASs. Data supporting ADD-RS=0 plus DDage-adj appear preliminary and require further 
27 scrutiny.




2 Acute aortic syndromes (AASs) are deadly cardiovascular emergencies involving the thoracic aorta. 
3 They include acute aortic dissection, intramural aortic hematoma, penetrating aortic ulcer and aortic rupture.1 
4 AASs represent unique diagnostic challenges because they are relatively rare diseases (4-6 cases/100.000 
5 individuals/year), but their presenting symptoms are unspecific and frequent in Emergency Department (ED) 
6 visits. For instance, chest pain accounts for 6% of ED visits (8-10 million visits/year in the US), abdominal 
7 pain for 6% and syncope for 2%.2-5 Conclusive diagnosis requires advanced imaging techniques, mostly 
8 contrast-enhanced computed tomography angiography (CTA), but owing to radiation, contrast exposure and 
9 resource limitations, CTA cannot be performed in all patients with AAS-compatible symptoms.6 
10 Consequently, decision on advanced imaging for suspected AASs is cumbersome, as shown by substantial 
11 variability in CTA ordering within emergency physicians, high misdiagnosis rates (up to 39%) and low 
12 diagnostic efficiency (as low as 2% of CTA exams turning out positive in North American series).7-9
13 For standardized clinical probability assessment of AASs, the reference tool indicated by guidelines is 
14 the aortic dissection detection risk score (ADD-RS), based on 12 risk factors organized in 3 categories 
15 (supplementary table 1).10,11 Using the ADD-RS, patients can be classified in 3 risk-categories (ADD-RS=0 or 
16 low risk, ADD-RS=1 or intermediate risk, ADD-RS>1 or high risk), or in 2 risk-categories (ADD-RS≤1 or 
17 low probability, ADD-RS>1 or high-probability). In guidelines by the European Society of Cardiology (ESC) 
18 and American College of Cardiology (ACC)/American Heart Association (AHA), standardized probability 
19 assessment, in association with thorough physical examination, history collection and clinical reasoning, 
20 designs a pipeline for standardized diagnostic evaluation of stable patients with suspected AASs. However, 
21 the ADD-RS does not substitute clinical reasoning and is not recommended by the American College of 
22 Emergency Physicians (ACEP) in isolation.12
23 D-dimer (DD), a fibrinogen degradation product well-established for the rule-out of pulmonary 
24 embolism (PE), is also a highly sensitive and moderately specific biomarker of AASs.13,14 The standard DD 
25 cutoff for AASs is 500 ng/mL. A key determinant of DD specificity is age, with a higher incidence of false 
26 positive results in elderly patients. For PE rule-out, application of an age-adjusted DD (DDage-adj) increases 
27 specificity and efficiency without affecting sensitivity.15 Two studies have reported that also for AASs, DDage-
28 adj may increase specificity with a small trade-off in sensitivity.16,17 A single cutoff for PE and AASs could be 
Page 24 of 60Academic Emergency Medicine
For Review Only
3
1 very practical, as both conditions are invariably considered in differential diagnosis in patients with truncal 
2 pain and both imply decision on CTA.18
3 The rationale of integrating ADD-RS with DD testing is that very few cases of AASs are predicted to 
4 occur in patients with ADD-RS=0 or ≤1 and a negative DD test result.14,19  In the present study, we aimed to 
5 provide a systematic review of studies evaluating the integration of ADD-RS with DD. For diagnostic variables 
6 with low statistical heterogeneity across studies, we aimed to determine pooled estimates. In order to also 






13 The study protocol was registered in the international prospective register of systematic reviews 
14 (PROSPERO) website, with CRD42019137508. This study followed PRISMA statement and the 
15 recommendations included in the Cochrane Handbook Accuracy and in the PRISMA-DTA statement.20,21 
16 Institutional review board ethical approval was not needed because of the reviewing nature of this study.
17
18 Search strategy
19 In June 2019, we conducted a thorough online search on MEDLINE, EMBASE and Web Of Science 
20 databases. Detailed search strategies are presented in table 1. We subsequently hand-searched the reference 
21 lists of all articles identified in our searches and of systematic reviews and meta-analyses on this topic.
22
23 Inclusion/exclusion criteria
24 Two investigators independently reviewed the titles and abstracts of the studies to assess eligibility. 
25 The full text article of the potentially eligible articles was next obtained to evaluate inclusion/exclusion criteria. 
26 Any disagreement was solved by consensus. The study design was gathered from Asha et al., representing the 
27 reference meta-analysis for DD in AASs.14 Studies were included if: (1) they were original research primarily 
28 assessing integration of ADD-RS with DD for the diagnosis of AASs; (2) they were cross-sectional diagnostic 
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1 studies; (3) prospective or retrospective enrollment was based on one or more AAS-compatible symptoms 
2 amongst chest pain, abdominal pain, back pain, syncope, perfusion deficit; (4) the ADD-RS was calculated; 
3 (5) the DD level was measured; (6) the diagnosis was confirmed or excluded with satisfactory criteria 
4 (advanced imaging with CTA, transesophageal echocardiography, magnetic resonance angiography, 
5 aortography, surgery or autopsy; in alternative, clinical case adjudication based on clinical data review and/or 
6 follow-up data); (7) absolute numbers of true positive, true negative, false positive, and false negative were 
7 reported or could be derived. 
8 Studies were excluded if the design was case-control or case series due to high potential biases and the 
9 impossibility to calculate pre-test probability.22 Conference abstracts were excluded because they are not peer-
10 reviewed, the results may not be final and insufficient detail is provided for quality assessment.
11
12 Data extraction and analysis
13 The reporting of this systematic review follows the Preferred Reporting Items for a Systematic Review 
14 and Meta-analysis of Diagnostic Test Accuracy Studies (PRISMA-DTA checklist, provided as supplementary 
15 tables 2-3).21 Two reviewers extracted data independently from the selected articles. The extracted data 
16 included: first author, date of publication, study period, number of study sites, study setting, study design, 
17 inclusion/exclusion criteria, number of participants analyzed and excluded, D-dimer assay used, D-dimer 
18 reference range, reference standard used. They also extracted the study population characteristics (age, gender, 
19 time from symptom onset to evaluation), ADD-RS distribution, D-dimer level, AAS subtype, alternative final 
20 diagnoses made for patients without AASs, reporting the absolute number of true positive (TP), true negative 
21 (TN), false positive (FP), false negative (FN). 
22 Two investigators independently assessed the quality of study design using the QUADAS-2 tool and 
23 the quality of reporting using the STARD tool.23,24 QUADAS-2 assessment was done in compliance with the 
24 original background document.23 For the domain “patient selection”, we identified a high risk of bias if the 
25 sample was not consecutive, if the study wasn’t done in the ED, if symptoms leading to patient inclusion did 
26 not include at least chest pain (representing the most common presenting symptom of AASs) and if patient 
27 enrollment was based on results of D-dimer or advanced imaging and not on clinical presentation. For the 
28 domain “index test”, we identified a high risk of bias if the threshold of the index test wasn’t prespecified or 
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1 if the result of the index test was interpreted after applying the reference standard. For the domain “reference 
2 standard”, a high risk of bias was identified if patients were not subjected to advanced aortic imaging (CTA, 
3 transesophageal echocardiography, magnetic resonance angiography or aortography), surgery or autopsy. For 
4 patients not subjected to advanced imaging, surgery or autopsy, case adjudication based on independent 
5 clinical data review and/or follow-up data was considered satisfactory.  For the domain “flow and timing”, a 
6 high risk of bias was identified if studies included a significant (>5%) proportion of patients evaluated >14 
7 days after symptom onset. Agreement between the reviewers was assessed with Cohen’s k statistic. Types of 
8 diagnostic bias and anticipated skews in observed sensitivity/specificity were evaluated according to Kohn et 
9 al.22
10 Based on clinical reasoning and previous evidence, we planned to analyze the DD test results based 
11 on two different cutoffs: 500 ng/mL and an age-adjusted cutoff (DDadj).18 For the latter, the DD result was 
12 interpreted as follows: in patients younger than 50 years, an AAS was excluded in those with a DD value lower 
13 than 500 ng/mL. In patients aged 50 years or older, the DD test result was considered negative in those with a 
14 DD value lower than their age multiplied by 10. Briefly, DDadj (ng/mL) was calculated as: age (years) × 10 
15 ng/mL (with a minimum of 500 ng/mL).15 To conduct an individual patient-level meta-analysis, the authors of 
16 all the selected studies were contacted to obtain missing data. For each study, a database was obtained reporting 
17 for each included patient, the age in years, the ADD-RS, the absolute DD level and the final diagnosis. 
18 In the meta-analysis, we analyzed the performance of the following integrated strategies for diagnostic 
19 rule-out of AASs (i.e. if string satisfied, rule-out AASs): (1) ADD-RS≤1 and DD<500 ng/mL; (2) ADD-RS≤1 
20 and DD<DDage-adj; (3) ADD-RS=0 and DD<500 ng/mL; (4) ADD-RS=0 and DD<DDage-adj. We built 2 x 2 
21 contingency tables for each diagnostic strategy using the number of true positive (TP), false positive (FP), false 
22 negative (FN), true negative (TN). For negative likelihood ratio (LR) values of strategies with a sensitivity of 
23 100%, contingency tables with zero value were handled by adding a 0.5 continuity correction and the 95% CI 
24 was estimated using a bootstrapping approach.25 The failure rate was calculated as FN / (FN+TN), i.e. number 
25 of patients with AASs satisfying rule-out criteria divided by the total number of patients satisfying rule-out 
26 criteria.26 The rule-out efficiency was calculated as (TN+FN) / (TP+FP+TN+FN), i.e. number of patients ruled-
27 out by each integrated strategy divided by total number of patients tested. Heterogeneity was determined using 
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1 the Higgins’ I2. For variables showing non-significant heterogeneity, we calculated pooled values using fixed 
2 or random models as appropriate, based on inter- and intra-study variability. 
3 The Pauker and Kassirer decision threshold model was applied to calculate two theoretical thresholds: 
4 a testing threshold (i.e. the probability of AAS at which there is no difference between performing the test and 
5 withholding the treatment) and a test-treatment threshold (i.e. the probability of AAS at which there is no 
6 difference between performing the test and administering the treatment).27 





12 Within 680 studies identified by the systematic database research, 12 studies were selected for full-
13 text review (figure 1) and 4 studies met all the inclusion criteria.16,28-30 Three studies were designed to 
14 investigate the diagnostic test characteristics of ADD-RS plus DD<500 ng/mL,28-30 and one investigated the 
15 integration of ADD-RS with DD<DDage-adj.16 The study characteristics are summarized in table 2 and the final 
16 diagnoses of the participant patients are detailed in supplementary table 43. The case-mix of AASs was similar 
17 amongst studies, with acute aortic dissection representing the most frequent subtype and intramural aortic 
18 hematoma or penetrating aortic ulcer accounting for most of the other cases. Some specificities were found in 
19 the study by Kotani et al., which included a larger number of patients with complicated aneurysms 
20 (ruptured/with impending-rupture or infectious).16 This study also reflects the higher prevalence of intramural 
21 hematomas in Japan and Asia. The pooled prevalence of AASs (mean ± SD) across the four studies was 18.0% 
22 ± 5.3%, which is substantially higher than reported in North American ED series, but also substantially lower 
23 than in most diagnostic biomarker studies, including the first key prospective multicenter study of D-dimer.9,31-
24 33 The pooled prevalence of “classic” acute aortic dissection was 67.3%, of intramural aortic hematoma was 
25 18.7% and of penetrating aortic ulcer was 6.8%. A higher observed prevalence of AASs than in general ED 
26 practice could lead to spectrum bias (falsely raising sensitivity and specificity).
27 The study by Nazerian et al. (2018) was the only prospective multicenter study. Its primary aim was 
28 to define the failure rate of a diagnostic rule-out strategy integrating ADD-RS (=0 or ≤1) with DD<500 
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1 ng/mL.30 A secondary analysis applying DDage-adj has also been published.17 In this trial, the gold standards for 
2 case-adjudication were conclusive aortic imaging (by CTA, transesophageal echocardiography or magnetic 
3 resonance angiography), surgery or autopsy. Enrollment preceded final decision on aortic imaging, and 
4 patients who were not subjected to any of these gold standards during the ED visit were subjected to 14-day 
5 follow-up. Patients or family members were interviewed by telephone with a structured questionnaire or 
6 underwent an outpatient visit after ED discharge, evaluating diagnosis of any aortic disease, subsequent ED 
7 visits, hospital admission and death. Reviewers defining case adjudication had access to hospital charts and 
8 dismissaldischarge documents. Gold standard imaging was obtained during the index visit in 45% of patients, 
9 and during follow-up in 1.6% of patients. Patients dismissed from the ED and with a negative follow-up were 
10 34.3%, potentially leading to differential verification bias, with a decrease in observed sensitivity and 
11 specificity. During follow-up, 2 patients were lost and 3 cases of AASs were diagnosed. Three patients died 
12 without advanced imaging or surgery. They all had a positive DD test result and therefore could not be regarded 
13 as potential FN cases.
14 The studies by Nazerian et al. (2014), Gorla et al. and Kotani et al. were retrospective.16,28,29 In these 
15 studies, an exact time definition of symptoms triggering enrolmentenrollment was not reported by the authors. 
16 This raises concern about the potential inclusion of patients with non-acute symptoms, in whom the chance of 
17 FN cases is higher. In the study by Nazerian et al. (2014), data were obtained from a registry of ED patients 
18 undergoing advanced aortic imaging for clinically suspected AAS.28 The study cohort largely overlapped with 
19 another study from the same groups which focused on validation of the ADD-RS per se.34 For 29% of enrolled 
20 participants, a DD test result was not available, leading to patient exclusion. This could introduce partial 
21 verification bias (which could raise sensitivity), but the characteristics of the patients in the included and 
22 excluded groups were similar. A post-hoc analysis showed that only 17 patients (1.6%) presented with history 
23 of pain >14 days; 4 of them had an AAS. One of these patients (symptoms for 15 days), had a normal D-dimer. 
24 However, exact time data was missing for 39.2% of the enrolled patients.  
25 In Gorla et al.,29 patients were enrolled if they were admitted to the ED for chest pain and if they were 
26 subjected to a DD assay. These criteria could bias against atypical presentations not involving chest pain. The 
27 clinical judgment of the physician ordering DD was not recorded. Hence, PE and not AAS could have 
28 represented the chief differential diagnosis in some patients. Indeed, the rate of PE in this cohort was 14.5%, 
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1 significantly higher than in the other studies. The authors declare that in study patients, CTA was used per 
2 guidelines, based on clinical judgment and on DD test result. All diagnoses of AASs were confirmed by 
3 advanced aortic imaging. Since the actual number of patients subjected to advanced imaging is unknown and 
4 clinical case adjudication was not based on a pre-specified follow-up, observed sensitivity could be raised due 
5 to differential verification bias.
6 In the study by Kotani et al.,16 patients were also enrolled if they presented with acute chest pain and 
7 if they received a DD assay. The exact time interval from symptom onset to sampling was not presented, and 
8 the DD assay was used per a pre-specified hospital protocol not detailed in the manuscript. The analysis was 
9 conducted only on patients admitted to hospital after the ED visit, while patients dismissed from the ED were 
10 excluded. This could lead to spectrum bias, raising sensitivity in the enrolled sample. Restriction to admitted 
11 patients potentially biases towards a more clinically severe population, while rule-out strategies ideally apply 
12 to patients in whom early ED dismissaldischarge represents a meaningful option. However, the final 
13 prevalence of AASs was 13.9%, indicating adequate representation of low-probability patients. Additional 
14 exclusion criteria were ST elevation on ECG and hemodynamic instability. Both criteria are in line with ESC 
15 recommendations, as patients with these clinical characteristics are not amenable to rule-out criteria.11 The DD 
16 assay was interpreted using the DDage-adj cutoff. As in Gorla et al., enrolmentenrollment criteria focused on 
17 chest pain, excluding alternative clinical presentations and likely included patients with a clinical suspicion of 
18 PE and not only of AASs. However, the prevalence of PE was generally low (3.8%), while the prevalence of 
19 acute coronary syndromes was the highest, indicating potential bias towards coronary artery disease.
20
21 Quality assessment
22 The quality assessment (QA) conducted using the QUADAS-2 is shown in table 3 and in 
23 supplementary figure 1. For only one study, the judgment was “low” in all 7 domains, indicating an overall 
24 low risk of bias and concern regarding applicability.30 In one study, the judgment was “low” in 3 of 7 
25 domains.29 
26 The quality of reporting of the included studies, analyzed according to the STARD 2015 statement, is 
27 detailed in supplementary table 54. Most studies showed suboptimal quality regarding type of sample 
28 enrollment, how missing data on the index test and reference standard were handled, sample size calculation, 
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1 whether any clinical intervention was done between the index test and the reference standard, study registration 
2 and accessibility of the full protocol. The agreement between the reviewers for components of the study quality 
3 assessment tools was good (κ=0.67, 95% CI 0.54 – 0.80).35
4
5 Meta-analysis
6 A total of 3804 patients were included in the meta-analysis, including 675 (17.7%) with AASs. To 
7 evaluate strategies integrating either the 500 ng/mL or the DDage-adj cutoff, individual patient-level data were 
8 used. Contingency tables and coupled forest plots were obtained (figure 2). For all strategies, statistical 
9 heterogeneity was negligible for sensitivity (I2=0%) and significant for specificity values. Subanalyses 
10 excluding patients with ADD-RS=0, shown in supplementary tables 5-6-7, indicated that results were not 
11 substantially affected by inclusion of patients at lowest pre-test probability of AASs. Negative and positive 
12 likelihood ratio (LR) values of the diagnostic strategies are shown in figure 3. Heterogeneity was negligible 
13 for the negative LR (I2=0%) and significant for the positive LR values of the diagnostic strategies.
14 Forest plots of failure rate and efficiency values are shown in figures 4-5. Failure rate values had low 
15 to moderate heterogeneity for ADD-RS=0 and DD<500 ng/mL (I2=38.1%), ADD-RS=0 and DD<DDage-adj 
16 (I2=28%), ADD-RS≤1 and DD<500 ng/mL (I2=39%); heterogeneity was significant for ADD-RS≤1 plus 
17 DD<DDage-adj (I2=84.4%). Efficiency values had significant heterogeneity for all diagnostic strategies. 
18 Pooled estimates of diagnostic variables underlying diagnostic rule-out (sensitivity, negative LR and 
19 failure rate) and showing non-significant heterogeneity across studies are summarized in table 4. Diagnostic 
20 variables showing high heterogeneity were not to reported, as limited inference on pooled values can be done. 
21 For ADD-RS=0 and DD<500 ng/mL, pooled sensitivity was 99.9% (99.3–100%), negative LR 0.032 (0–0.086) 
22 and failure rate 0.1% (0–0.3%). For ADD=0 and DD<DDage-adj sensitivity was 99.9% (99.3–100%), negative 
23 LR 0.027 (0–0.081) and failure rate 0.1% (0–0.2%). For ADD-RS≤1 and DD<500 ng/mL, sensitivity was 
24 98.9% (97.9–99.9%), negative LR 0.025 (0.001–0.049) and failure rate 0.6% (0.2–0.9%). For ADD-RS≤1 and 
25 DD<DDage-adj, sensitivity was 97.6% (96.3–98.9%) and negative LR 0.048 (0.022–0.074). For this strategy, 
26 pooled failure was not computed due to significant heterogeneity.
27
28 Test-treatment threshold
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1 Test-treatment thresholds were calculated for diagnostic strategies including DD<500 ng/ml 
2 (supplementary figure 2). According to this model, the ADD-RS=0 and DD<500 ng/mL strategy should be 
3 performed if the clinical probability of AASs is between 1.7% and 23.2%, while the ADD-RS≤1 and DD<500 




8 We provide a systematic review and summary of studies assessing integration of ADD-RS with DD 
9 for diagnosis of AASs. Only four papers satisfied the pre-defined inclusion criteria, underlying the relative 
10 paucity of data. However, the total number of included patients was substantial (n=3804). All studies post-
11 dated the latest guidelines of the American Heart Association and the European Society of Cardiology, and 
12 only one (Nazerian et al. 2014) was cited in the latest clinical policy of the American College of Emergency 
13 Physicians.11,12,36 One was a prospective multicenter trial, while the other 3 were retrospective studies. All were 
14 performed in the ED and mostly involved patients with chest pain, but inclusion criteria partly differed. This 
15 key limit reflects the absence of a standard definition of patients suspected of having AASs and amenable to 
16 rule-out strategies. Therefore, methodological and clinical heterogeneity between available studies mandate 
17 caution in efforts to pool and summarize data.
18 Significant statistical heterogeneity was found for specificity, positive LR and efficiency. This likely 
19 reflects differences in the clinical case-mix of study cohorts. For these variables, data pooling could be 
20 misleading and was therefore omitted. AASs cases were instead homogenous across studies, thus leading to 
21 negligible statistical heterogeneity for sensitivity and negative LR values and allowing meaningful data 
22 pooling for these variables. Also in a previous meta-analysis of high-quality studies (which also included 
23 Nazerian et al. 2014), the heterogeneity was low for sensitivity and negative LR, and substantial for specificity 
24 and positive LR.14  
25 Acquisition of primary data allowed us to evaluate diagnostic strategies incorporating also DDage-adj, 
26 already in use for PE rule-out. When using ADD-RS=0, DDage-adj provided pooled sensitivity and negative LR 
27 values similar to those of the “classical” 500 ng/mL cutoff. Instead, when using ADD-RS≤1, DD<500 ng/mL 
28 outperformed DD<DDage-adj in terms of pooled sensitivity and negative LR. This data suggests that DD<DDage-
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1 adj could be evaluated in further studies only if the pre-test probability is presumed to be very low. DDage-adj 
2 might provide increased specificity over 500 ng/mL, but the statistical heterogeneity found across studies does 
3 not allow any conclusion. 
4 Consensus is lacking on what should reproducibly define a clinical suspicion of AASs. Hence, 
5 differences between physicians and centers can be profound. In North American retrospective series of patients 
6 undergoing CTA for suspected AAS, the prevalence of AASs was 3%.8,37 In a vast out-of-hospital study 
7 evaluating the ADD-RS in non-traumatic emergencies, the prevalence of AASs was 0.9%.38 In the studies 
8 reviewed herein, the prevalence of AASs was 13 to 23%. Application of rule-out strategies to patient 
9 populations at lower pre-test probability of AASs is expected to result in lower failure rates, with a trade-off 
10 in efficiency.
11 Caution is needed when considering application of ADD-RS and D-dimer based strategies in clinical 
12 practice. First, ADD-RS, a decision rule derived from a retrospective register of AASs, has low specificity.37 
13 In addition, ADD-RS derivation methods have not been published, and it is currently unknown whether use of 
14 the ADD-RS provides any advantage in terms of diagnostic accuracy and of CTA ordering, as compared to 
15 clinical gestalt.39,40 In the future, focused ED-centered studies may provide alternative and more specific 
16 probability assessment tools. Second, also D-dimer also lacks specificity. Therefore, indiscriminate application 
17 of ADD-RS and D-dimer to unselected ED patients with AAS-compatible symptom(s) would paradoxically 
18 increase the number of CTA ordered. Such slippery slope must be avoided.41 
19 Based on previous data, in terms of specificity, we speculate that the ADD-RS/D-dimer rule-out 
20 pathway could best apply to stable patients with ADD-RS=1 owing to clinical manifestations providing per se 
21 higher specificity (i.e. pulse deficit, neurological deficit, aortic valve insufficiency).42 Caution is needed in 
22 patients with hypotension, which also potentially defines clinical instability and might prompt towards a fast-
23 track for advanced imaging irrespective of D-dimer test results. However, in clinical practice, most cases with 
24 ADD-RS=1 will be driven by pain features (severe, sudden, ripping pain), providing higher sensitivity but 
25 lower specificity. To maximize benefits, a pragmatic approach could be to request D-dimer only after three-
26 dimensional evaluation of clinical history, physical examination, first-line imaging and blood test results, in 
27 patients still lacking a clear alternative diagnosis, or in whom  rule-out of AASs is considered imperative for 
28 decision on hospital admission versus discharge or administration of anticoagulant/antiplatelet therapies, 
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5 Only one study (49% of patients) was judged to provide a low risk of bias/applicability concerns.30 
6 Two studies (42% of patients)16,28 had issues in one of the QUADAS domains, and one study (10% of patients) 
7 had a generally lower quality profile.29 In one study, the case-mix of AASs slightly differed, with fewer cases 
8 of acute aortic dissections and higher prevalence of the other forms.16 Overall, the potential bias types most 
9 frequently encountered were: (1) partial verification bias, due to patients excluded because discharged from 
10 the ED or due to unavailable DD test result (leading to potential upward skew in sensitivity and downward 
11 skew in specificity), and (2) differential verification bias, due to inclusion of patients subjected to clinical 
12 follow-up without advanced aortic imaging (leading to potential downward skew in sensitivity and specificity). 
13 The accuracy of DD for diagnosis of AASs may also slightly differ amongst subtypes, with higher risk of false 
14 negative cases in patients with intramural hematomas and focal dissections.43,44 Therefore, methodological and 
15 clinical heterogeneity between available studies mandate caution in data pooling and summarization.
16 A key issue affecting two studies (24% of patients) is that the authors selected patients with chest pain 
17 and a DD test result, potentially also introducing also individuals with suspected PE.16,29 In clinical terms, this 
18 aspect may be secondary, because both PE and AASs are typically considered in differential diagnosis, share 
19 DD as the key biomarker and require CTA for conclusive diagnosis. A suspicion of AAS by the attending 
20 physicians was clearly defined in two studies (76% of patients) led by the same primary investigators.28,30 This 
21 might limit external validity.
22 With the exception of the ADvISED trial, there was general uncertainty about the timing of the index 
23 test. Hence, a minority of patients with symptoms dating >14 days were possibly enrolled, including few cases 
24 of AASs in their subacute or chronic phase. Since D-dimer levels tend to reducedecrease over time after 
25 development of AASs, this is expected to increase the number of patients with AASs presenting as FN 
26 (differential verification bias, with potential downward skew in estimates of sensitivity and failure rate).45
27
28




2 Only 4 studies have evaluated integration of ADD-RS with DD for diagnosis of AASs, with 
3 methodological differences that must be carefully considered. However, the total number of included patients 
4 is reasonably large (n=3804), and negligible heterogeneity was found for sensitivity and negative LR values. 
5 Available studies consistently show that ADD-RS=0 or ≤1 plus DD<500 ng/mL are highly sensitive diagnostic 
6 strategies and support their reliability for rule-out of AASs. For DDage-adj, available data appear largely 
7 preliminary and further studies are required. Nonetheless, further prospective trials, especially in low 
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13 Figure 1. PRISMA flow diagram of study search and selection.
14
15 Figure 2. Contingency tables and coupled forest plots of sensitivity and specificity values. Heterogeneity was 
16 determined using the Higgins’ I2.
17
18 Figure 3. Forest plots of the negative and positive likelihood ratio values. Heterogeneity was determined 
19 using the Higgins’ I2.
20
21 Figure 4. Forest plots of the failure rate values. Heterogeneity was determined using the Higgins’ I2.
22
23 Figure 5. Forest plots of the efficiency values. Heterogeneity was determined using the Higgins’ I2.




Table 1. Detailed database search strategies.
Literature database Search query
MEDLINE (((("Aneurysm, Dissecting"[Mesh]) AND "Fibrin Fibrinogen Degradation 
Products"[Mesh]) OR (acute aortic syndrome AND D-dimer))) OR "Aortic 
Dissection Detection Risk Score")
EMBASE (('acute aortic syndrome'/exp OR 'acute aortic syndrome' OR 'aortic 
dissection'/exp OR 'aortic dissection') AND ('d dimer'/exp OR 'd dimer') OR 
'aortic dissection detection risk score') NOT 'conference abstract':it NOT 
review:it NOT letter:it
Web Of Science TOPIC: (("acute aortic syndrome" OR "aortic dissection" OR "dissecting 
aneurysm" OR "Aortic Dissection Detection Risk Score") AND ("D-dimer" OR 
"Fibrin Degradation Product"))
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Table 2. Characteristics of included studies.
Nazerian, 2014 Gorla, 2017 Kotani, 2017 Nazerian, 2018
Study period 01/2008 to 03/2013 01/2001 to 05/2014 01/2011 to 04/2014 01/2014 to 12/2016
























420 (29%) 0 (0%) 66 (6.9%) 48 (2.5%)
AASs, N (% enroll.)
   AD, N (% AAS)
   IMH, N (% AAS)
   PAU, N (% AAS)






















(N, % with AAS)
   0
   1























perfusion deficit + 
alt-D not
 established + 
clinical suspicion 
leading to CTA
chest pain + D-
dimer available at 
presentation
acute chest pain + 
admission to 
hospital + D-dimer 
available
chest/back/abdomin
al pain, syncope or 
perfusion deficit + 
clinical suspicion
Exclusion criteria NR NR
hemodynamic 
instability, STEMI, 
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in ED, referral to 
other hospital






CTA, TEE, MRA, 




Age, y mean (SD) 67 (14%) 63 (12%) 70 (14%) 62 (12%)
Male, % 66% 61% 63.4% 62.3%
Duration of 
symptoms, hours
















<500 ng/ml ≤500 ng/ml
if age ≤50y: < 500 
ng/ml




   sensitivity 









AAS: acute aortic syndrome; AD: aortic dissection; alt-D: alternative diagnosis; BR: Brazil; CTA: computed 
tomography angiography; GE: Germany; IMH: intramural aortic hematoma; IQR: interquartile range; IT: Italy; 
JA: Japan; MRA: magnetic resonance angiography; NR: not reported; PAU: penetrating aortic ulcer; SD: 
standard deviation; SW: Switzerland; TEE: transesophageal echocardiography. 
*Values reported as median (IQR). §Original data provided by the authors for the present analysis and not 
included in the original manuscript. #Includes: ruptured aortic aneurysm (7.3%), impending rupture of aortic 
aneurysm (10.6%), infectious aortic aneurysm (3.2%). ¶Includes only spontaneous (non-traumatic) rupture of 
thoracic aorta.
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Table 3. Assessment of study quality according to QUADAS-2.23














Nazerian, 2014 L L L U L L L
Gorla, 2017 H L U U L L U
Kotani, 2017 H L L L L L L
Nazerian, 2018 L L L L L L L
L =Low-risk, H =High-risk, U =Unclear
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1 in 1000 
(333–∞)
     I-squared, p 0%, 0.95 0%, 0.64 38.1%, 0.18






1 in 1000 
(500–∞)
     I-squared, p 0%, 0.95 0%, 0.77 28%, 0.24








     I-squared, p 0%, 0.91 0%, 0.98 39%, 0.19





     I-squared, p 0%, 0.86 0%, 0.56 84.4%, <0.001
LR: likelihood ratio; n.a.=not applicable due to significant heterogeneity.
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Figure 1. PRISMA flow diagram of study search and selection. 
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Figure 2. Contingency tables and coupled forest plots of sensitivity and specificity values. Heterogeneity was 
determined using the Higgins’ I2. 
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Figure 3. Forest plots of the negative and positive likelihood ratio values. Heterogeneity was determined 
using the Higgins’ I2. 
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Figure 4. Forest plots of the failure rate values. Heterogeneity was determined using the Higgins’ I2. 
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Figure 5. Forest plots of the efficiency values. Heterogeneity was determined using the Higgins’ I2. 
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Supplementary table 1. Aortic Dissection Detection Risk Score (ADD-RS). 
 
High-risk conditions 
• Marfan syndrome 
• Family history of aortic disease 
• Known aortic valve disease 
• Recent aortic manipulation 
• Known thoracic aortic aneurysm 
High-risk pain features 
Chest, back, or abdominal pain described as: 
• Abrupt in onset 
• Severe in intensity 
• Ripping or tearing in quality 
High-risk exam features 
• Pulse deficit or systolic BP differential 
• Focal neurologic deficit (with pain) 
• Murmur of aortic insufficiency (new, with pain) 
• Hypotension or shock state 
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Supplementary table 2. Prisma-DTA checklist for abstracts, from McInnes MDF et al. 
 
Section/topic  # PRISMA-DTA for Abstracts Checklist item  
Reported on page # 
of the manuscript 
TITLE and PURPOSE  
Title  1 Identify the report as a systematic review (+/- meta-analysis) of diagnostic test accuracy 
(DTA) studies. 
1 




Eligibility criteria 3 Include study characteristics used as criteria for eligibility. - 
Information sources 4 List the key databases searched and the search dates. 1 (no dates) 
Risk of bias & applicability 5 Indicate the methods of assessing risk of bias and applicability. 1 
Synthesis of results A1 Indicate the methods for the data synthesis.  
RESULTS  
Included studies 6 Indicate the number and type of included studies and the participants and relevant 
characteristics of the studies (including the reference standard). 
1 
Synthesis of results 7 Include the results for the analysis of diagnostic accuracy, preferably indicating the 
number of studies and participants. Describe test accuracy including variability; if meta-
analysis was done, include summary results and confidence intervals. 
1 
DISCUSSION  
Strengths and limitations 9 Provide a brief summary of the strengths and limitations of the evidence 1 
Interpretation 10 Provide a general interpretation of the results and the important implications. 1 
OTHER   
Funding  11 Indicate the primary source of funding for the review. - 
Registration  12 Provide the registration number and the registry name - 
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Supplementary table 3. Final diagnoses of patients in the included studies. 
 Nazerian, 2014 Gorla, 2017 Kotani, 2017 Nazerian, 2018 
AASs, n (%tot) 233 (22.5) 85 (22.6) 123 (13.9) 241 (13.0) 
Stanford Type-A AD, N (%AAS) 148 (63.5) 33 (38.8) 27 (22.0)§ 125 (51.9) 
Stanford Type-B AD, N (%AAS) 51 (21.9) 28 (32.9) 20 (16.3)§ 53 (22.0) 
IMH, N (%AAS)  31 (13.33) 11 (12.9) 42 (34.1) 35 (14.5) 
PAU, N (%AAS) 3 (1.3) 13 (15.3) 8 (6.5) 10 (4.1) 
Aortic rupture, N (%AAS) 0 0 26 (21.1)* 18 (7.5) 
     
Alt. diagnoses, N (%tot) 802 (77.5) 291 (77.3%) 764 (86.1) 1607 (87) 
Acute coronary syndrome, N (%AltD) 94 (12) 19 (6.5) 528 (69.1) 244 (13.2) 
Stable angina, N (%AltD) NR 35 (12.0%) 57 (7.5) NR 
Pulmonary embolism, N (%AltD) 13 (2) 42 (14.5) 29 (3.8) 30 (1.6) 
Non complicated aortic aneurism, N (%AltD) NR 0 NR 53 (2.9) 
Syncope, N (%AltD) 66 (8) 0 NR 78 (4.2) 
Pleuritis, N (%AltD) NR 29 (10.0) NR 57 (3.1) 
Pericarditis, N (%AltD) 25 (3.1) 0 25 (3.3) 54 (2.9) 
Limb/organ ischemia, N (%AltD) 12 (1.2) 0 1 (0.1) 2 (0.1) 
Muscle-skeletal pain, N (%AltD) 302 (37.7) 166 (57.0) NR 485 (26.2) 
Gastrointestinal, N (%AltD) 73 (9.1) 0 5 (0.7) 191 (10.3) 
Stroke, N (%AltD) 16 (2) 0 NR 15 (0.8) 
Other, N (%AltD) 201 (19.4) 0 119 (15.6) 398 (21.5) 
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AASs: acute aortic syndromes; Alt.: alternative; NR: not reported. *Includes rupture, impending-rupture and infectious aortic aneurysm. §Original data 
provided by the authors for the present analysis and not included in the original manuscript. 
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1 Identification as a study of diagnostic accuracy using at least one measure of accuracy  Yes Yes Yes Yes 
2 Structured summary of study design, methods, results, and conclusions  Yes Yes Yes Yes 
3 
Scientific and clinical background, including the intended use and clinical role of the index 
test 
Yes Yes Yes Yes 
4 Study objectives and hypotheses Yes Yes Yes Yes 
5 Whether is a prospective or retrospective study Yes Yes Yes Yes 
6 Eligibility criteria  Yes Yes Yes Yes 
7 On what basis potentially eligible participants were identified  Yes Yes Yes Yes 
8 Where and when potentially eligible participants were identified  Yes Yes Yes Yes 
9 Whether participants formed a consecutive, random or convenience series Yes Unclear Unclear Yes 
10a Index test, in sufficient detail to allow replication Yes Yes Yes Yes 
10b Reference standard, in sufficient detail to allow replication Yes Unclear Yes Yes 
11 Rationale for choosing the reference standard (if alternatives exist) Yes Unclear Yes Yes 
12a Definition of and rationale for test positivity cut-offs or result categories of the index test Yes Yes Yes Yes 
12b 
Definition of and rationale for test positivity cut-offs or result categories of the reference 
standard 
Yes Yes Yes Yes 
13a 
Whether clinical information and reference standard results were available to the 
performers/readers of the index test 
Yes Yes Yes Yes 
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Whether clinical information and index test results were available to the assessors of the 
reference standard 
Yes Yes Yes Yes 
14 Methods for estimating or comparing measures of diagnostic accuracy Yes Yes Yes Yes 
15 How indeterminate index test or reference standard results were handled Yes Yes Yes Yes 
16 How missing data on the index test and reference standard were handled Yes Unclear Unclear Yes 
17 Any analyses of variability in diagnostic accuracy Yes Yes Yes Yes 
18 Intended sample size and how it was determined No No No Yes 
19 Flow of participants, using a diagram Yes Yes Yes Yes 
20 Baseline demographic and clinical characteristics of participants Yes Yes Yes Yes 
21a Distribution of severity of disease in those with the target condition Yes Yes Yes Yes 
21b Distribution of alternative diagnoses in those without the target condition Yes Yes Yes Yes 
22 Time interval and any clinical interventions between index test and reference standard No No No No 
23 
Cross tabulation of the index test results (or their distribution)  
by the results of the reference standard 
Yes Yes Yes Yes 
24 Estimates of diagnostic accuracy and their precision Yes Yes Yes Yes 
25 Any adverse events from performing the index test or the reference standard No No No No 
26 
Study limitations, including sources of potential bias, statistical uncertainty, and 
generalisability 
Yes Yes Yes Yes 
27 Implications for practice, including the intended use and clinical role of the index test Yes Yes Yes Yes 
28 Registration number and name of registry No No No Yes 
29 Where the full study protocol can be accessed No No No Yes 
30 Sources of funding and other support; role of funders Yes Yes Yes Yes 
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Supplementary table 5. Contingency table and meta-analysis of sensitivity and specificity values in the included studies, excluding patients with ADD-
RS=0, for ADD-RS=1 and DD<500 ng/mL. 
 
 
TP FP FN TN Total Sensitivity (95% CI) Specificity (95% CI) 
Nazerian 2014 212 349 2 150 713 99.1% (96.7% - 99.9%) 30.1% (26.1% - 34.3%) 
Gorla 2017 82 48 2 55 187 97.6% (91.7% - 99.7%) 53.4% (43.3% - 63.3%) 
Kotani 2017 111 219 1 139 470 99.1% (95.1% - 99.9%) 38.8% (33.7% - 44.1%) 
Nazerian 2018 227 554 2 628 1411 99.1% (96.9% - 99.9%) 53.1% (50.2% - 56.0%) 
        
Pooled estimate 
     
98.7% (97.6% - 99.4%) 43.5% (31.2% - 56.3%) 
I2 
     
0% (p = 0.74) 96.6% (p<0.001) 
 
Heterogeneity was determined using the Higgins’ I2. 
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Supplementary table 6. Contingency table and meta-analysis of sensitivity and specificity values in the included studies, excluding patients with ADD-
RS=0, for ADD-RS=1 and DD<DDage-adj. 
 
 
TP FP FN TN Total Sensitivity (95% CI) Specificity (95% CI) 
Nazerian 2014 207 324 7 175 713 96.7% (93.4% - 98.7%) 35.1% (30.9% - 39.4%) 
Golra 2017 81 42 3 61 187 96.4% (89.9% - 99.3%) 59.2% (49.1% - 68.8%) 
Kotani 2017 109 180 3 178 470 97.3% (92.4% - 99.4%) 49.7% (44.4% - 55.0%) 
Nazerian 2018 225 487 4 695 1411 98.3% (95.6% - 99.5%) 58.8% (55.9% - 61.6%) 
        
Pooled estimate 
     
97.1% (95.7% - 98.3%) 50.5% (38.1% - 62.8%) 
I2 
     
0% (p=0.68) 96.4% (p<0.001) 
 
Heterogeneity was determined using the Higgins’ I2. 
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Supplementary figure 1. Graphical display of QUADAS-2 results. 
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Ttesting threshold= [(Ppos/nd) × (Rrx) + Rt] ÷ [(Ppos/nd ×Rrx) + (Ppos/d × Brx)] = 1.7%
Ttreatment threshold= [(Pneg/nd) × (Rrx)–Rt] ÷ [(Pneg/nd ×Rrx) + (Pneg/d × Brx)] = 23.2%
Ppos/nd = probability of a positive result in patients without disease = 1 – specificitya = 1 – 0.19 = 0.81 
Pneg/nd = probability of a negative result in patients without disease = specificitya = 0.19
Rrx = risk of treatment in patients without disease = 0.010b  
Rt = risk of diagnostic test = 0.0003c  
Ppos/d = probability of a positive result in patients with disease = sensitivity = 0.99
Pneg/d = probability of a negative result in patients with disease = 1 – sensitivity = 1 – 0.99 = 0.01 
Brx = benefit of treatment in patients with disease = 0.50d 
0% 50% 100%
1.7% 23.2%





Clinical probability of acute aortic syndrome
(a) ADD-RS =0 and D-dimer <500 ng/mL











Ttesting threshold= [(Ppos/nd) × (Rrx) + Rt] ÷ [(Ppos/nd ×Rrx) + (Ppos/d × Brx)] = 1.1%
Ttreatment threshold= [(Pneg/nd) × (Rrx)–Rt] ÷ [(Pneg/nd ×Rrx) + (Pneg/d × Brx)] = 44.8%
Ppos/nd = probability of a positive result in patients without disease = 1 – specificitya = 1 – 0.46 = 0.54 
Pneg/nd = probability of a negative result in patients without disease = specificitya = 0.46
Rrx = risk of treatment in patients without disease = 0.010b  
Rt = risk of diagnostic test = 0.0003c  
Ppos/d = probability of a positive result in patients with disease = sensitivity = 0.99
Pneg/d = probability of a negative result in patients with disease = 1 – sensitivity = 1 – 0.99 = 0.01 




Clinical probability of acute aortic syndrome
apooled specificity
bbased on Taylor RA, Iyer NS. A decision analysis to determine a testing threshold for computed tomographic 
angiography and D-dimer in the evaluation of aortic dissection. Am J Emerg Med 2013 Jul;31(7):1047-55.
cbased on Cochran ST. Anaphylactoid reactions to radiocontrast media. Curr Allergy Asthma Rep. 2005 
Jan;5(1):28-314
destimated from mortality of treated and untreated type A (surgical treatment) and type B (medical treatment) 
aortic dissection (from Taylor RA et al.).
Supplementary figure 2. Test-treatment threshold analysis. 
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